PsA is a chronic, inflammatory disease in and around the joints as well as the surrounding tendons and ligaments. It is ...

MoonLake Immunotherapeutics (MLTX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.

Sicca is not a feature of RA. Psoriatic arthritis (PSA) is a type of arthritis linked to the autoimmune skin condition ...

Similar percentages of patients with PsA receiving secukinumab vs adalimumab achieved an ACR20 response at 12 weeks.

The following is a summary of “Association between depression and anxiety and inability to achieve remission in rheumatoid ...

Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced the completion of the dosing and initial follow-up period for ...

Psoriatic arthritis looks different for each of the 1.5 million Americans who have the disease - but speak to people who are ...

Bernstein is one of 830,000 Americans living with a chronic, inflammatory disease known as psoriatic arthritis (PsA). She recently partnered with Novartis’ PsAvor Life campaign to inspire others ...

Treatment with IV secukinumab led to rapid improvements in the signs and symptoms of PsA, which were maintained through 52 weeks.

Global Healthy Living Foundation has 12 posters and Polymyalygia Rheumataca, Psoriasis and RA Research at American College of ...

Gold treatment for psoriatic arthritis is to slow down inflammation and prevent joint damage. In addition to that, we're trying to prevent these spurs from happening and fusing of joints.

Anyone can develop psoriatic arthritis, but it’s most common in people who already have psoriasis, affecting about 30 percent of people with the skin condition. Whether you’re managing just ...